
Arima Genomics
@arimagenomics
Gain unparalleled access to the 3D structure of the genome. Identify how spatial and temporal changes alter gene regulation and cellular function. #3DGenomics
ID: 1905830484
http://www.arimagenomics.com 26-09-2013 00:08:43
1,1K Tweet
1,1K Followers
824 Following




We’re excited to be at The Genetics Society's Epigenetics 2025: From Mechanisms to Disease! If you’re in Belfast attending, stop by Booth 3 and connect with our expert Liz to discuss the latest in epigenetics and how #3DGenomics can advance your projects. #Epigenetics2025



Today marks National #DNA Day, honoring the discovery of the DNA double helix🧬 and the completion of the Human Genome Project National Human Genome Research Institute. But DNA is more than just a sequence, it’s a 3D structure packed inside the nucleus, shaping gene regulation, genome function, and disease




🚨 Only 2 days left! Don’t miss our upcoming webinar: “From Structure to Susceptibility: Decoding Alzheimer’s Risk in the 3D Genome of Microglia”-May 7th! Join us as we explore how advanced 3D genome and epigenomic technologies are unlocking new insights into Alzheimer’s disease

🚨 The wait is over! We’re thrilled to announce the winners of our 2025 Multi-Omics Grant. Congrats to Dr. Terry Furey (UNC School of Medicine), Dr. Jonathan Rennhack (LoyolaStritch), and Abdalla Ahmed (Stanford Medicine), who will harness 3D genomics to push the boundaries of IBD, metastatic

We’re excited to see SEQanswers' spotlight recent advances in genome assembly—and proud to have our own Ibrahim Jivanjee, Senior Director of Marketing & Product Management, quoted in the article! Ibrahim shared how our #3DGenomics and Hi-C technologies are enabling


Last week's full webinar is out now! Hear from Dr. Coline Arnould (UC San Francisco), whose expertise in DNA repair and 3D genome architecture brings powerful new perspectives to gene regulation. Watch the recording here: hubs.la/Q03qzrJs0 #3DGenomics #GeneRegulation

Today we announce the appointment of Tom Willis, PhD, as CEO and the close of a $22 million Series C financing led by Illumina Ventures. This marks a strategic pivot as we strengthen our focus on transforming #oncology testing: hubs.ly/Q03spp1D0


Are you at #EACR2025? Our Breakfast Symposium starts in 1 hour! Hear from Joanna Achinger-Kawecka how transposable elements are reactivated in drug-resistant breast cancer and their unexpected role as regulatory enhancers. Coffee and pastries will be served! We are also at Booth #36. Today's


📢 A fantastic team of researchers led by @melissazhao, including Anthony Schmitt and Kristin Sikkink, published a study in @bloodadvances which highlights “chromosomal mimicry” in blood cancers—where traditional tests misidentify key rearrangements. Their work is shedding new light



Unlocking hidden cancer drivers just became possible. Discover how @NYULangone, Children's Hospital Colorado, UC San Diego Health Moores Cancer Center, @scrippshealth, Morgan Adams Foundation, used Arima Genomics’ Hi-C technology to detect gene fusions and chromosomal rearrangements in FFPE tumor specimens—variants missed by


Attending the CGC Conference next week? Visit us at Booth #12 to see how Aventa FusionPlus and Aventa Lymphoma tests uncover actionable fusions and rearrangements missed by other methods. Anthony Schmitt will also be presenting at our Platinum Showcase on Monday, Aug 4,
